Avior Wealth Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Avior Wealth Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$604K	Buy	5,440 +790	+17%	+$71.4K	0.02%	469
2026 Q1	$404K	Buy	4,650 +1,078	+30%	+$105K	0.01%	586
2025 Q4	$382K	Buy	3,572 +31	+0.9%	+$3.29K	0.01%	540
2025 Q3	$358K	Sell	3,541 -2,094	-37%	-$194K	0.01%	543
2025 Q2	$356K	Buy	5,635 +1,046	+23%	+$64K	0.01%	525
2025 Q1	$243K	Buy	+4,589	New	+$255K	0.01%	604
2024 Q2	–	Sell	-10	Closed	-$433	–	3442
2024 Q1	$433	Buy	+10	New	+$438	﹤0.01%	2607

Other funds holding RYTM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

EWP

Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Avior Wealth Management's RYTM Position: Q2 2026 in Review

Avior Wealth Management increased its Rhythm Pharmaceuticals (RYTM) stake by 17% in Q2 2026, buying an estimated $71.4K and bringing the position to 5,440 shares worth $604K. The position accounts for 0.02% of the portfolio, ranked #469.

Avior Wealth Management first reported a position in RYTM in Q1 2024 and has held it in 7 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Avior Wealth Management held 5,440 shares of Rhythm Pharmaceuticals worth $604K as of Q2 2026.
Avior Wealth Management bought 790 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $71.4K.
Rhythm Pharmaceuticals made up 0.02% of Avior Wealth Management's portfolio in Q2 2026, its #469 holding.
Avior Wealth Management first reported a position in Rhythm Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.